BRPI0913630A2 - solid dosage pharmaceutical formulation and, amorphous form of compound - Google Patents

solid dosage pharmaceutical formulation and, amorphous form of compound

Info

Publication number
BRPI0913630A2
BRPI0913630A2 BRPI0913630A BRPI0913630A BRPI0913630A2 BR PI0913630 A2 BRPI0913630 A2 BR PI0913630A2 BR PI0913630 A BRPI0913630 A BR PI0913630A BR PI0913630 A BRPI0913630 A BR PI0913630A BR PI0913630 A2 BRPI0913630 A2 BR PI0913630A2
Authority
BR
Brazil
Prior art keywords
compound
pharmaceutical formulation
solid dosage
amorphous form
dosage pharmaceutical
Prior art date
Application number
BRPI0913630A
Other languages
Portuguese (pt)
Inventor
Aaron J Moment
Dan Zhang
Majid Mahjour
Original Assignee
Merck Sharp & Dohme
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Sharp & Dohme filed Critical Merck Sharp & Dohme
Priority claimed from PCT/US2009/049009 external-priority patent/WO2010002763A1/en
Publication of BRPI0913630A2 publication Critical patent/BRPI0913630A2/en

Links

BRPI0913630A 2008-06-30 2009-06-29 solid dosage pharmaceutical formulation and, amorphous form of compound BRPI0913630A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US16654208P 2008-06-30 2008-06-30
PCT/US2009/049009 WO2010002763A1 (en) 2008-06-30 2009-06-29 Solid dosage formulations of telcagepant potassium

Publications (1)

Publication Number Publication Date
BRPI0913630A2 true BRPI0913630A2 (en) 2015-10-27

Family

ID=54541582

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0913630A BRPI0913630A2 (en) 2008-06-30 2009-06-29 solid dosage pharmaceutical formulation and, amorphous form of compound

Country Status (1)

Country Link
BR (1) BRPI0913630A2 (en)

Similar Documents

Publication Publication Date Title
BRPI0906467A2 (en) pharmaceutical dosage form
DK2346495T4 (en) PHARMACEUTICAL FORMULATION 514
SMT201400069B (en) Pharmaceutical formulation
BRPI0906962A2 (en) Compound and pharmaceutical composition
BRPI0906556A2 (en) Compound and pharmaceutical composition
ZA201005015B (en) Solid pharmaceutical dosage form
IT1394860B1 (en) PHARMACEUTICAL COMPOUNDS
BRPI0912026A2 (en) homeopathic formulation
BRPI0908132A2 (en) Benzodiazepine Compound and Pharmaceutical Composition
BRPI0921654A2 (en) pharmaceutical formulation
BRPI0917681A2 (en) Compound and pharmaceutical composition
BRPI0922804A2 (en) solid dosage forms of bendamustine
DK2285413T3 (en) Pharmaceutical composition
BRPI0807078A2 (en) COMPOUND AND PHARMACEUTICAL FORMULATION
DK2285359T3 (en) Solid form drug formulation with delayed excretion
BR112012000831A2 (en) related compounds, pharmaceutical compositions and methods
BRPI0922806A2 (en) bendamustine oral dosage forms
BRPI0921313A2 (en) pharmaceutical composition
BRPI0812964A2 (en) SOLID ORAL PHARMACEUTICAL DOSAGE FORM
DK2271618T3 (en) Pharmaceutical compounds
DK2391351T3 (en) Pharmaceutical composition comprising 2-oxo-1-pyrrolidine derivatives
BR112012031102A2 (en) solid oral dosage form
IT1393930B1 (en) PHARMACEUTICAL COMPOUNDS
BR112012015016A2 (en) pharmaceutical formulation and enteric pharmaceutical dosage form
BRPI0818702A2 (en) Pharmaceutical formulation of clavulanic acid

Legal Events

Date Code Title Description
B08F Application fees: dismissal - article 86 of industrial property law

Free format text: REFERENTE AS 4A, 5A E 6A ANUIDADES.

B08K Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87)

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.